Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lymphadenopathy associated with severe hypertriglyceridemia.

D A Leaf1, D R Illingworth, W E Connor

  • 1Department of Medicine, University of California School of Medicine, Los Angeles.

JAMA
|August 8, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Which are the greatest recent discoveries and the greatest future challenges in nutrition?

European journal of clinical nutrition·2007
Same author

Effects of colesevelam HC1 on sterol and bile acid excretion in patients with type IIa hypercholesterolemia.

Digestive diseases and sciences·2005
Same author

Premenopausal black women are uniquely at risk for coronary heart disease compared to white women.

Preventive cardiology·2002
Same author

Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus.

The American journal of cardiology·2001
Same author

n-3 Fatty acids from fish and fish oil: panacea or nostrum?

The American journal of clinical nutrition·2001
Same author

Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial.

Pediatrics·2001
Same journal

Online Prescribing of GLP-1 Receptor Agonists.

JAMA·2026
Same journal

Using AI Disagreement to Expose Gaps in Coverage Rules.

JAMA·2026
Same journal

Randomized Trials in Pregnancy.

JAMA·2026
Same journal

Randomized Trials in Pregnancy-Reply.

JAMA·2026
Same journal

WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

JAMA·2026
Same journal

FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

JAMA·2026
See all related articles

Severe hypertriglyceridemia, a rare form of high cholesterol, can cause diffuse lymphadenopathy. This previously undescribed association should be considered in diagnosing enlarged lymph nodes.

Area of Science:

  • Internal Medicine
  • Endocrinology
  • Hematology

Background:

  • Diffuse lymphadenopathy presents a broad differential diagnosis in clinical practice.
  • Hypertriglyceridemia, particularly severe forms, requires careful clinical evaluation.

Observation:

  • A case study of a patient presenting with diffuse lymphadenopathy was analyzed.
  • The patient exhibited severe hypertriglyceridemia, classified as type V hyperlipidemia.

Findings:

  • A novel association between severe hypertriglyceridemia (type V hyperlipidemia) and diffuse lymphadenopathy was identified.
  • This specific link between hyperlipidemia and lymphadenopathy has not been previously documented in medical literature.

Implications:

Related Experiment Videos

  • The findings suggest that type V hyperlipidemia should be incorporated into the differential diagnosis for patients with diffuse lymphadenopathy.
  • This expands the understanding of metabolic disorders' potential systemic manifestations.
  • Clinicians should consider lipid profiles in the workup of unexplained lymphadenopathy.